Additional Information
Book Details
Abstract
A study guide for practicing cardiologists preparing for ABIM recertification as well as fellows preparing for initial certification.
- Complements in-depth texts by summarizing the key facts necessary for success with an emphasis on ACC/AHA guideline recommendations.
- Maximizes your study time by focusing exclusively on high-yield material explicitly geared for the ABIM Cardiovascular Disease Exam.
“Dr. Sawyer‘s text is the perfect complement to a review course. Rather than furiously taking notes, you can instead focus on the material because the notes are here.”
- Marko Yakovlevitch, MD
Table of Contents
| Section Title | Page | Action | Price |
|---|---|---|---|
| Cover | i | ||
| Title Page | iii | ||
| Copyright | iv | ||
| Dedication | v | ||
| Contents | vii | ||
| Preface | ix | ||
| Chapter 1: Acute Coronary Syndrome | 1 | ||
| ANTIPLATELET/ANTICOAGULANT STRATEGIES | 1 | ||
| UA/NSTEMI—INVASIVE VS. CONSERVATIVE APPROACH | 1 | ||
| STEMI | 3 | ||
| POST-INFARCT COMPLICATIONS | 4 | ||
| REFERENCES | 6 | ||
| Chapter 2: Chronic CAD | 7 | ||
| ANGINA DEFINITION | 7 | ||
| CCS ANGINA CLASSIFICATION | 7 | ||
| PRETEST PROBABILITY OF CAD | 8 | ||
| STRESS TESTING | 8 | ||
| NONINVASIVE RISK STRATIFICATION | 11 | ||
| TREATMENT OF CHRONIC ISCHEMIC HEART DISEASE | 11 | ||
| REVASCULARIZATION OF CHRONIC ISCHEMIC CAD | 12 | ||
| REFERENCES | 13 | ||
| Chapter 3: Acute CHF | 15 | ||
| HEART FAILURE HEMODYNAMIC PROFILES | 15 | ||
| FACTORS COMMONLY PRECIPITATING HEART FAILURE | 16 | ||
| MEDICAL THERAPY | 17 | ||
| REFERENCES | 19 | ||
| Chapter 4: Chronic CHF | 21 | ||
| NYHA CLASSIFICATION | 21 | ||
| ACC/AHA CLASSIFICATION | 21 | ||
| STANDARD MEDICAL THERAPY FOR CHF WITH REDUCED EF ( ≤ 40%) | 22 | ||
| HEART FAILURE WITH PRESERVED EJECTION FRACTION | 22 | ||
| DEVICE THERAPY | 24 | ||
| MECHANICAL CIRCULATORY SUPPORT | 24 | ||
| TRANSPLANT | 25 | ||
| REFERENCES | 27 | ||
| Chapter 5: Hypertrophic Cardiomyopathy | 29 | ||
| HYPERTROPHIC CARDIOMYOPATHY | 29 | ||
| REFERENCES | 31 | ||
| Chapter 6: Cardiac Channelopathies | 33 | ||
| BRUGADA SYNDROME | 33 | ||
| CATECHOLAMINERGIC POLYMORPHIC VENTRICULAR TACHYCARDIA | 34 | ||
| LONG QT SYNDROME (LQTS) | 34 | ||
| REFERENCE | 35 | ||
| Chapter 7: Supraventricular Arrhythmias | 37 | ||
| ATRIAL FIBRILLATION (AF) | 37 | ||
| ATRIAL FLUTTER | 39 | ||
| AV NODAL REENTRANT TACHYCARDIA (AVNRT) | 41 | ||
| AV REENTRANT TACHYCARDIA (AVRT) | 43 | ||
| AFIB AND WPW | 45 | ||
| REFERENCES | 45 | ||
| Chapter 8: Ventricular Arrhythmias and Defibrillators | 47 | ||
| CLASS I INDICATIONS FOR ICD IMPLANTATION | 47 | ||
| CLASS III | 47 | ||
| RIGHT VENTRICULAR OUTFLOW TRACT TACHYCARDIA | 48 | ||
| FASCICULAR VT | 49 | ||
| ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA | 50 | ||
| REFERENCES | 52 | ||
| Chapter 9: Bradycardia/Pacemakers | 53 | ||
| PACEMAKERS | 54 | ||
| REFERENCES | 56 | ||
| Chapter 10: Valvular Heart Disease | 57 | ||
| AORTIC STENOSIS | 57 | ||
| AORTIC INSUFFICIENCY | 58 | ||
| MITRAL STENOSIS | 59 | ||
| MITRAL REGURGITATION | 61 | ||
| TRICUSPID STENOSIS | 63 | ||
| TRICUSPID REGURGITATION | 63 | ||
| PULMONIC STENOSIS | 63 | ||
| MECHANICAL PROSTHETIC VALVE ANTICOAGULATION | 65 | ||
| BIOPROSTHETIC VALVE ANTICOAGULATION | 65 | ||
| REFERENCES | 65 | ||
| Chapter 11: Endocarditis | 67 | ||
| DIAGNOSIS OF ENDOCARDITIS | 67 | ||
| CLASS I SURGICAL INDICATIONS | 68 | ||
| ENDOCARDITIS PROPHYLAXIS | 69 | ||
| DEVICE INFECTION | 70 | ||
| REFERENCES | 70 | ||
| Chapter 12: Hypertension | 71 | ||
| DEFINITIONS | 71 | ||
| INTERVENTION | 71 | ||
| TREATMENT GOAL | 71 | ||
| SECONDARY HYPERTENSION | 71 | ||
| SPECIFIC CAUSES OF SECONDARY HYPERTENSION | 73 | ||
| RESISTANT HTN | 75 | ||
| HYPERTENSIVE EMERGENCIES | 75 | ||
| HYPERTENSION IN PREGNANCY | 76 | ||
| REFERENCES | 76 | ||
| Chapter 13: Syncope | 79 | ||
| PHYSIOLOGY OF VASOVAGAL SYNCOPE | 79 | ||
| SUBCLAVIAN STEAL | 80 | ||
| ORTHOSTATIC HYPOTENSION | 80 | ||
| CAROTID SINUS HYPERSENSITIVITY | 81 | ||
| CLASS I INDICATIONS FOR TILT TABLE TESTING | 82 | ||
| EP STUDY IN THE EVALUATION OF SYNCOPE | 82 | ||
| REFERENCES | 82 | ||
| Chapter 14: Vascular Disease | 83 | ||
| PERIPHERAL ARTERIAL DISEASE | 83 | ||
| CAROTID ARTERIAL DISEASE | 84 | ||
| ATHEROSCLEROTIC RENAL ARTERY STENOSIS | 85 | ||
| SUBCLAVIAN ARTERIAL DISEASE | 85 | ||
| DEEP VEIN THROMBOSIS | 86 | ||
| REFERENCES | 87 | ||
| Chapter 15: Diseases of the Aorta | 89 | ||
| THORACIC AORTIC ANEURYSM (TAA) | 89 | ||
| AORTIC DISSECTION | 91 | ||
| ABDOMINAL AORTIC ANEURYSM | 94 | ||
| VASCULITIDES | 94 | ||
| REFERENCES | 95 | ||
| Chapter 16: Heart Disease in Women and Pregnancy | 97 | ||
| PRIMARY PREVENTION | 97 | ||
| PHYSIOLOGY OF PREGNANCY | 97 | ||
| CONDITIONS WITH INCREASED MATERNAL RISK DURING PREGNANCY | 98 | ||
| VALVULAR HEART DISEASE IN PREGNANCY | 98 | ||
| CONGENITAL HEART DISEASE IN PREGNANCY | 100 | ||
| HYPERTENSION IN PREGNANCY | 102 | ||
| ANTIARRHYTHMICS | 103 | ||
| ANTICOAGULATION IN PREGNANCY | 103 | ||
| REFERENCES | 103 | ||
| Chapter 17: Adult Congenital Heart Disesase - Simple Lesions | 105 | ||
| LEFT-TO-RIGHT SHUNT LESIONS | 105 | ||
| OBSTRUCTIVE LESIONS | 109 | ||
| REFERENCES | 110 | ||
| Chapter 18: Adult Congenital Heart Disease - Complex Lesions | 111 | ||
| CONGENITAL CORONARY ANOMALIES | 111 | ||
| CORONARY AV FISTULA | 111 | ||
| EISENMENGER SYNDROME | 112 | ||
| TETRALOGY OF FALLOT (TOF) | 112 | ||
| TRANSPOSITION OF THE GREAT ARTERIES (TGA) | 114 | ||
| EBSTEIN’S ANOMALY | 115 | ||
| TRICUSPID ATRESIA / SINGLE VENTRICLE | 116 | ||
| DEXTROCARDIA | 116 | ||
| CONGENITAL SURGERIES TO KNOW | 117 | ||
| CONGENITAL SYNDROMES AND ASSOCIATIONS TOKNOW | 118 | ||
| REFERENCES | 119 | ||
| Chapter 19: Pulmonary Hypertension | 121 | ||
| WHO CLASSIFICATION | 121 | ||
| WORKUP OF PULMONARY HYPERTENSION | 122 | ||
| RIGHT HEART CATHETERIZATION | 123 | ||
| GROUP I TREATMENT | 124 | ||
| GROUP II TREATMENT | 125 | ||
| GROUP III TREATMENT | 125 | ||
| GROUP IV TREATMENT | 125 | ||
| REFERENCES | 126 | ||
| Chapter 20: Restriction/Constriction/Tamponade | 127 | ||
| RESTRICTIVE AND INFILTRATIVE CARDIOMYOPATHY | 127 | ||
| CONSTRICTIVE PERICARDITIS | 128 | ||
| DISTINGUISHING CONSTRICTION FROM RESTRICTION | 129 | ||
| CARDIAC TAMPONADE | 130 | ||
| RIGHT ATRIAL PRESSURE WAVEFORMS | 131 | ||
| ACUTE PERICARDITIS | 132 | ||
| REFERENCES | 132 | ||
| Chapter 21: Perioperative Cardiovascular Evaluation and Management | 135 | ||
| SURGICAL RISK CATEGORIES | 135 | ||
| SURGICAL RISK FACTORS | 136 | ||
| PREOPERATIVE WORKUP | 136 | ||
| KEY POINTS | 137 | ||
| PERIOPERATIVE MANAGEMENT OF ANTIPLATELET AGENTS POST-PCI | 137 | ||
| REFERENCES | 137 | ||
| Chapter 22: Essential Cardiovascular Manifestations and Care of Rheumatologic Diseases | 139 | ||
| REFERENCES | 144 | ||
| Chapter 23: Cardiac Manifestations of Endocrine Disease | 145 | ||
| HYPERTHYROIDISM / THYROTOXICOSIS | 145 | ||
| HYPOTHYROIDISM | 145 | ||
| ADRENAL INSUFFICIENCY | 146 | ||
| CUSHING SYNDROME | 146 | ||
| PHEOCHROMOCYTOMA | 146 | ||
| PRIMARY ALDOSTERONISM | 147 | ||
| ACROMEGALY | 147 | ||
| PRIMARY HYPERPARATHYROIDISM | 148 | ||
| REFERENCES | 148 | ||
| Chapter 24: Hyperlipidemia | 149 | ||
| LIPOPROTEIN TRANSPORT PATHWAYS | 150 | ||
| STATINS | 150 | ||
| FIBRATES | 150 | ||
| MAJOR NON-LDL RISK FACTORS | 151 | ||
| TREATMENT RECOMMENDATIONS | 151 | ||
| PCSK9 INHIBITORS | 152 | ||
| GENETIC DYSLIPIDEMIAS | 153 | ||
| REFERENCES | 154 | ||
| Chapter 25: Cardiac Tumors | 155 | ||
| METASTATIC TUMORS | 155 | ||
| MALIGNANT PRIMARY TUMORS | 155 | ||
| BENIGN PRIMARY TUMORS | 156 | ||
| BENIGN EXTRACARDIAC TUMORS | 156 | ||
| REFERENCES | 156 | ||
| Chapter 26: Therapeutic Hypothermia | 157 | ||
| CURRENT GUIDELINES | 157 | ||
| EXCLUSIONS | 158 | ||
| REFERENCES | 158 | ||
| Chapter 27: Biostatistics and Essential Calculations/Values | 159 | ||
| ESSENTIAL STATISTICS | 159 | ||
| HYPOTHESIS TESTING | 161 | ||
| BASIC CALCULATIONS / VALUES | 162 | ||
| REFERENCES | 164 | ||
| Chapter 28: Physical Exam Essentials | 167 | ||
| BASIC PRINCIPLES | 167 | ||
| VALVULAR LESIONS | 169 | ||
| HEMODYNAMIC MANEUVERS | 172 | ||
| SPECIFIC CONDITIONS | 173 | ||
| PREGNANCY | 174 | ||
| RA / JUGULAR VENOUS WAVEFORM | 175 | ||
| REFERENCES | 175 | ||
| Chapter 29: Pharmacology Essentials | 177 | ||
| VAUGHAN WILLIAMS CLASSIFICATION | 177 | ||
| ANTIARRHYTHMIC OPTIONS IN ATRIALFIBRILLATION | 178 | ||
| IMPORTANT DRUG EFFECTS / INTERACTIONS | 179 | ||
| COMMON VASOACTIVE DRUGS | 181 | ||
| REFERENCES | 182 |